Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell February 24, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy February 9, 2026
[ALPS] “Ketika ini, ramai pakar di seluruh dunia, sedang berlumba-lumba untuk menghasilk” June 25, 2020
